Navigation Links
UCB and Emory partner to address pressing public health issues for people living with epilepsy
Date:3/25/2013

ATLANTA, March 25, 2013 /PRNewswire/ -- A research collaboration to analyze the clinical factors that impact epilepsy care and outcomes was announced today by the Department of Neurology at Emory University School of Medicine and UCB, a leading biopharmaceutical company. This work is part of an innovative research collaboration that seeks to identify factors and approaches that achieve optimal response in epilepsy patients.

Epilepsy is a chronic neurological disorder defined as two or more unprovoked seizures. According to the Centers for Disease Control and Prevention, epilepsy is one of the most common diseases of the central nervous system, and it affects more than 2 million people in the United States.  Importantly, one in 26 people in the United States will develop epilepsy at some point in their lifetime.  A recent special issue of The Lancet highlighted the significant unmet medical needs in epilepsy and called on public health officials to treat this disease as a global health priority.

"This research collaboration is an opportunity to use real world, patient-level data to address a critical need for the epilepsy community," said study lead Sandra Helmers , M.D., M.P.H., professor of Neurology and Pediatrics at Emory. "Once we can identify the most important drivers of epilepsy outcomes, we can address gaps that exist today and provide better care for people living with epilepsy."

This collaboration, which is modeled after similar academia and industry drug discovery collaborations, focuses on real world disease and subsequent clinical and economic health outcomes. In the first project, investigators will use de-identified patient-level data from an administrative claims database to better understand characteristics of people living with epilepsy, including demographics.

Dr. Helmers is joined by
'/>"/>

SOURCE UCB
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Fantastic flash memory combines graphene and molybdenite
2. Self-assembled nanostructures enable a low-power phase-change memory for mobile electronic devices
3. NIST mechanical micro-drum used as quantum memory
4. NextBio Teams With Emory University and the Aflac Cancer Center to Improve Outcomes for Children with Medulloblastoma
5. UCLA engineers develop new energy-efficient computer memory using magnetic materials
6. Computer memory could increase fivefold from advances in self-assembling polymers
7. Stress breaks loops that hold short-term memory together
8. Future memory
9. Carbon-based transistors ramp up speed and memory for mobile devices
10. Penn researchers study of phase change materials could lead to better computer memory
11. Transparent memory chips are coming
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 27, 2015 Dr. Robert Hanzlik, whose ... toxicity carries implications for advancing the creation of safer ... National University , the second-largest private, nonprofit university ... Hanzlik, a professor at the University of Kansas School ... design, starts at 5 p.m. and takes place at ...
(Date:4/27/2015)... April 27, 2015 ... please scroll to bottom . Investor-Edge ... Pharmaceuticals Inc. (NASDAQ: LXRX ), Idera Pharmaceuticals ... (NASDAQ: SNTA ), Spectrum Pharmaceuticals Inc. (NASDAQ: ... MDVN ). Free research report on Lexicon Pharma ...
(Date:4/27/2015)... and HEIDELBERG , Germany ... Addresses unmet need in treatment of millions of ... has been granted a patent in Europe ... patent supports Molecular Health,s discovery that EPHB4 is a novel ... promotes tumor growth. EPO stimulates the production of red blood ...
(Date:4/27/2015)... 2015 Diasome Pharmaceuticals, Inc. (“Diasome”) ... Joslin Diabetes Center (“Joslin”) to collaborate on the ... novel Hepatocyte Directed Vesicle (“HDV”) targeting system for ... , Located in Boston, Massachusetts, Joslin is the ... organization dedicated to the prevention, treatment and cure ...
Breaking Biology Technology:Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 2Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 3Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 2Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 3Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 4Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 5Molecular Health Gains Patent for Novel Receptor Utilizing Computational Biomarker Discovery Technology 2Diasome Pharmaceuticals Announces Clinical Trial Design Collaboration 2
... Imago Scientific Instruments has sold one of ... of Engineering for use in the new W.M. ... lab will be the primary research center of ISU's ... Narasimhan, an associate professor of chemical and biological engineering. ...
... has secured $5 million in a funding round led ... LLC. , ,The funding will allow Jellyfish to ramp up ... conjunction with the funding, retail industry veteran Ralph Dillon, managing ... of Directors. , ,Jellyfish has gained traction in online retailing ...
... research team at the Medical College of Wisconsin ... National Heart, Lung, and Blood Institute to support ... which was awarded to an investigative team led by pediatric ... molecular and clinical understanding of Von Willebrand disease ...
Cached Biology Technology:Online retailer Jellyfish.com lands $5M in funding 2Online retailer Jellyfish.com lands $5M in funding 3Medical College secures $9.7M research grant 2
(Date:4/9/2015)... Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the third quarter of ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-438-5524 (conference ...
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
(Date:3/31/2015)...   Guidepoint , a leading global research services ... Management TRACKER, part of the Guidepoint TRACKER ... medical device and therapeutics markets. The Post-Surgical Pain Management ... market share, and adoption rates across three major modalities ... The Post-Surgical Pain Management TRACKER will provide ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... the American Society of Tropical Medicine and Hygiene (ASTMH) -- ... bring together in one place global experts who are battling ... that each year kill or sicken hundreds of millions of ... medicine and global health will present new insights and research ...
... N.C. -- Recognizing that some of the leading ... are located in the Research Triangle Park area, ... $13.6 million grant to establish a multi-university center ... scientific endeavor. Researchers from Duke University, North ...
... Bethesda, MDA new commentary published online in The FASEB ... diligent and demand proof of safety and benefit before ... treatments have very little scientific evidence that they actually ... the article, Phillip J. Baker, Ph.D., Executive Director of ...
Cached Biology News:Latest on malaria, dengue, radiation threats, bedbugs, cholera in Haiti at ASTMH Annual Meeting 2Latest on malaria, dengue, radiation threats, bedbugs, cholera in Haiti at ASTMH Annual Meeting 3NSF establishes Triangle (NC) Center for Soft Matter Research 2NSF establishes Triangle (NC) Center for Soft Matter Research 3Chronic pain: Watch out before accepting diagnosis and treatment 2